Is HIMS diluting shareholders? — Limited Dilution
Hims & Hers Health, Inc.'s share count has grown 11.6% over the last ~49 months, an annualized rate under 10% per year. Dilution exposure is within normal corporate-finance ranges.
Share-Count History — From HIMS Annual Filings
Convertible Notes — Cited Language
“nd JPMorgan Chase Bank, N.A., as administrative and collateral agent, which provides for a three-year senior secured revolving line of credit in an amount up to $175.0 million. In May 2025, we issued $1.0 billion aggregate principal amount of 0% convertible senior notes due 2030, the total net pr…”
“For additional details regarding the Credit Facility, see Note 13 – Debt to the consolidated financial statements included in Part II, Item 8 of this Annual Report on Form 10-K.In May 2025, we issued $1.0 billion aggregate principal amount of 0% convertible senior notes due 2030 (the “2030 Conver…”
What Dilution Means for HIMS Shareholders
Dilution refers to the reduction in existing shareholders' percentage ownership when a company issues new shares. Companies dilute for multiple legitimate reasons — funding growth, acquiring other companies, compensating employees with equity, or converting debt to equity. Whether dilution is good or bad depends on what the new capital is being used for and whether per-share value grows faster than the share count. For Hims & Hers Health, Inc., share count went from 196,695,342 on 2022-02-18 to 219,561,143 on 2026-02-20 — a change of 11.6% over approximately 49 months.
The dilution mechanism shareholders should monitor most closely is the presence of an ATM (at-the-market) equity facility. ATMs give the company standing authority to issue new shares into the open market at any time, often without separate shareholder notice. They create continuous-issuance overhang — even days when no new shares are sold, the facility itself weighs on the stock as supply might appear at any moment. Hims & Hers Health, Inc.'s most recent annual filing does not mention an ATM facility — though that status can change with each new financing round.
Convertible notes are a separate forward-dilution mechanism: each note converts into shares at a defined price (or formula) at maturity, automatically expanding share count. The presence of large convertible-note balances on the balance sheet — even before conversion — is a material signal that future dilution is contractually scheduled. Hims & Hers Health, Inc. has convertible notes outstanding per recent SEC filings. The cited language above shows the specific note series referenced. Conversion mechanics — strike price, ratio, floor — determine the magnitude of forward dilution exposure.
For broader context on HIMS's risk profile, see the HIMS Overview page. For audit-opinion status, see the Going Concern page.